Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 91.5% | 106.4% | 91.0% | 92.9% | 91.3% | 111.9% | 118.7% | 129.0% | 113.2% | 101.2% | 95.0% | 114.5% | 128.3% | 128.2% | 86.5% | 159.1% | 137.1% | 50.4% | 166.3% | 136.5% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 106.3%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Novartis AG have been 115.1% over the past three years, and 133.1% over the past five years.
As of today, Novartis AG's FCF to Net Income is 106.3%, which is lower than industry median of 109.5%. It indicates that Novartis AG's FCF to Net Income is Bad.